Unconfigured Ad

Collapse

Discussions about next gen sequencing service providers, reviews & experiences, etc. No overtly commercial content permitted without prior approval.

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by ECO, 12-16-2008, 07:59 PM
173 responses
229,824 views
0 reactions
Last Post vivianshaw  
Started by dan, 05-07-2013, 04:50 PM
3 responses
19,097 views
0 reactions
Last Post miles.collier@arosab.com  
Started by Sequencingenthusiast, 07-07-2025, 01:51 AM
1 response
348 views
0 reactions
Last Post David hoff  
Started by vivianshaw, 10-06-2022, 06:34 PM
0 responses
170 views
0 reactions
Last Post vivianshaw  
Started by vivianshaw, 10-06-2022, 06:29 PM
0 responses
167 views
0 reactions
Last Post vivianshaw  
Started by vivianshaw, 08-30-2022, 10:20 PM
0 responses
180 views
0 reactions
Last Post vivianshaw  
Started by vivianshaw, 08-30-2022, 10:09 PM
0 responses
243 views
0 reactions
Last Post vivianshaw  
Started by CZI_Czerwinski, 08-15-2022, 08:14 AM
0 responses
287 views
0 reactions
Last Post CZI_Czerwinski  
Started by vivianshaw, 08-03-2022, 07:12 PM
0 responses
210 views
0 reactions
Last Post vivianshaw  
Started by vivianshaw, 08-03-2022, 07:04 PM
0 responses
310 views
0 reactions
Last Post vivianshaw  
Started by vivianshaw, 07-02-2022, 08:45 PM
0 responses
205 views
0 reactions
Last Post vivianshaw  
Started by vivianshaw, 07-02-2022, 08:37 PM
0 responses
208 views
0 reactions
Last Post vivianshaw  
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM
  • SEQadmin2
    How Immunogenomics Decodes Immunity’s Genetic Blueprint
    by SEQadmin2




    The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

    This convergence of genetics, immunology, and computation...
    09-01-2026, 05:41 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Working...